Alpha 2.0
Login Register
» Articles » PMID: 22216492

Effect of a Metabolite of Diazepam, 3-hydroxydiazepam (temazepam), on Sleep in Man

Overview
Journal Br J Clin Pharmacol
Specialty Pharmacology
Date 2012 Jan 6
PMID 22216492
Citations 7
Authors
A N Nicholson
B M Stone
Affiliations
Soon will be listed here.
Abstract

The effect of 3-hydroxydiazepam (temazepam, 10 mg and 20 mg) on sleep was studied in six healthy adult males using electroencephalography for sleep measures, and analogue scales for subjective assessments of well-being and sleep quality. The effects were compared with diazepam (5 mg and 10 mg). Effect on total sleep time was restricted to the night of ingestion. There was no change in total sleep time after temazepam (10 mg), but with 20 mg total sleep time was increased (P = 0.01). Sleep onset latencies and awakenings were markedly reduced. Temazepam reduced the duration (min) of stage 0 (P = 0.05) and stage 1 (P = 0.01) sleep, and the effect on stage 1 was seen during each two hourly interval of sleep (P = 0.05). No effects were observed with stage 3, 3+4 and REM sleep, except that the appearance of the first REM period was delayed with temazepam (20 mg) (P = 0.001). The subjects, as a group, reported improved sleep, but subjective assessments of well-being were not altered. Correlations were calculated for sleep measures and subjective assessments.

Citing Articles

Psycho-social stress, insomnia and temazepam: a sleep laboratory evaluation in a "general practice" sample.

Beary M, Lacey J, Crutchfield M, Bhat A Psychopharmacology (Berl). 1984; 83(1):17-9.

PMID: 6146153 DOI: 10.1007/BF00427415.

Effect of temazepam and temazepam-ethanol on sleep.

Lehmann W, Liljenberg B Eur J Clin Pharmacol. 1981; 20(3):201-5.

PMID: 6116607 DOI: 10.1007/BF00544598.

Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic.

Heel R, Brogden R, Speight T, Avery G Drugs. 1981; 21(5):321-40.

PMID: 6112127 DOI: 10.2165/00003495-198121050-00001.

Pharmacokinetics of temazepam after day-time and night-time oral administration.

Muller F, van Dyk M, Hundt H, Joubert A, Luus H, Groenewoud G Eur J Clin Pharmacol. 1987; 33(2):211-4.

PMID: 2891534 DOI: 10.1007/BF00544571.

Human pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules.

Fuccella L, Bolcioni G, Tamassia V, Ferrario L, Tognoni G Eur J Clin Pharmacol. 1977; 12(5):383-6.

PMID: 598411 DOI: 10.1007/BF00562455.

References
1.
Tognoni G, Gomeni R, DE MAIO D, Alberti G, Franciosi P, Scieghi G . Pharmacokinetics of N-demethyldiazepam in patients suffering from insomnia and treated with nortriptyline. Br J Clin Pharmacol. 1975; 2(3):227-32. PMC: 1402583. DOI: 10.1111/j.1365-2125.1975.tb01580.x. View
2.
Fuccella L, Tosolini G, Moro E, Tamassia V . Study of physiological availability of temazepam in man. Int J Clin Pharmacol. 1972; 6(4):303-9. View
3.
Tansella M, Siciliani O, Burti L, Schiavon M, Zimmermann C, Gerna M . N-desmethyldiazepam and amylobarbitone sodium as hypnotics in anxious patients. Plasma levels, clinical efficacy and residual effects. Psychopharmacologia. 1975; 41(2):81-5. DOI: 10.1007/BF00421061. View
4.
Tansella M, Lader M . The residual effects of N-desmethyldiazepam in patients. Psychopharmacologia. 1974; 38(1):81-90. DOI: 10.1007/BF00421290. View
5.
Borland R, Nicholson A . Immediate effects on human performance of a 1,5-genzodiazepine (clobazam) compared with the 1,4-benzodiazepines, chlordiazepoxide hydrochloride and diazepam. Br J Clin Pharmacol. 1975; 2(3):215-21. PMC: 1402574. DOI: 10.1111/j.1365-2125.1975.tb01578.x. View